المؤلفون: Florence Granel-Brocard, Alain Dupuy, D. Legoupil, Jean-Jacques Grob, Marie Beylot-Barry, Marie-Thérèse Leccia, Jean-Philippe Arnault, Florence Brunet-Possenti, A. Bardet, Pierre-Emmanuel Stoebner, Céleste Lebbe, Stéphane Dalle, Eve Maubec, Clara Allayous, Isabelle Borget, Bernard Guillot, Brigitte Dréno, Julie DeQuatrebarbes, Philippe Saiag, Laurent Mortier, Marguerite Kandel, Sophie Dalac, Caroline Dutriaux, Thierry Lesimple, Stefan Michiels, Henri Montaudié, François Aubin

المساهمون: Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Institut Gustave Roussy (IGR), Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Service de biostatistique et d'épidémiologie (SBE), Direction de la recherche clinique [Gustave Roussy], Institut Gustave Roussy (IGR)-Institut Gustave Roussy (IGR), Immunologie humaine, physiopathologie & immunothérapie (HIPI (UMR_S_976 / U976)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Thérapies Laser Assistées par l'Image pour l'Oncologie - U 1189 (ONCO-THAI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Groupe hospitalier Saint-André, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Centre Hospitalier Universitaire [Grenoble] (CHU), Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), Hôpital Ambroise Paré [AP-HP], Centre Hospitalier Universitaire de Nice (CHU Nice), Service de dermatologie [CHU d'Amiens-Picardie], CHU Amiens-Picardie, AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Service de dermatologie, vénéreologie et cancérologie cutanée [Hôpital de la Timone - APHM], Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE), Centre Hospitalier Annecy-Genevois [Saint-Julien-en-Genevois], Service de dermatologie [Bordeaux], Université Bordeaux Segalen - Bordeaux 2-CHU Bordeaux [Bordeaux]-Hôpital Haut-Lévêque [CHU Bordeaux], CHU Bordeaux [Bordeaux], CRLCC Eugène Marquis (CRLCC), Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Avicennes University Hospital, Service de Dermatologie et Allergologie [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), Service de Dermatologie [Rennes] = Dermatology [Rennes], CHU Pontchaillou [Rennes], Service de dermatologie [Nantes], Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes), Oncostat (U1018 (Équipe 2)), Institut Gustave Roussy (IGR)-Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Centre Léon Bérard [Lyon], AP-HP. Université Paris Saclay, Amgen Pfizer Merck Novartis Roche Janssen Biotech Meso Scale Diagnostics, MSD Array BioPharma Takeda Pharmaceutical Company Sanofi Pasteur British Microcirculation Society, BMS Institut National Du Cancer, INCa: DOC 16‐009, This work was supported by the French National Cancer Institute (DOC 16‐009)., Stéphane Dalle reports institutional research funding Roche, institutional research funding and nonfinancial support from Bristol‐Myers Squibb (BMS), and an immediate family member who is employed by Sanofi and owns stock or other ownership interest in the company. Aurélie Bardet was employed by Roche and held stock and other ownership interest in the company until March of 2018. Clara Allayous reports nonfinancial support from BMS, Amgen, and Roche outside the submitted work. Laurent Mortier reports personal fees and nonfinancial support from Roche, Novartis, BMS, and Merck Sharp & Dohme (MSD) outside the submitted work. Caroline Dutriaux reports personal fees from Roche, BMS, Novartis, MSD, and Pierre Fabre Laboratories outside the submitted work. Philippe Saiag reports research funding and personal fees from Roche, grants, personal fees, and nonfinancial support from BMS, MSD, Novartis, and Pierre Fabre Laboratories, and personal fees from Array, Sanofi, and Merck, all outside the submitted work. Henri Montaudié reports institutional research funding from LeoPharma, institutional research funding, personal fees, and nonfinancial support from BMS, personal fees from Pierre Fabre Laboratories and MSD, and nonfinancial support from Novartis, all outside the submitted work. Jean‐Phillipe Arnault reports institutional research funding and personal fees from BMS and institutional research funding from Novartis outside the submitted work. Jean‐Jacques Grob reports personal fees and nonfinancial support from BMS, Roche, MSD, Novartis, Merck, Amgen, Pierre Fabre Laboratories, Sanofi, and Pfizer and nonfinancial support from Amgen, all outside the submitted work. Julie De Quatrebarbes reports nonfinancial support from BMS, MSD, and Janssen outside the submitted work. Thierry Lesimple reports research funding and personal fees from Roche and personal fees from BMS, MSD, Novartis, Pierre Fabre Laboratories, and Incyte, all outside the submitted work. François Aubin reports personal fees and nonfinancial support from Novartis, MSD, and Roche outside the submitted work. Eve Maubec reports grants, personal fees, and nonfinancial support from MSD, personal fees from Sanofi and Novartis, personal fees and nonfinancial support from BMS, and nonfinancial support from Pierre Fabre Laboratories, all outside the submitted work. Stefan Michiels reports personal fees from IDDI Belgium, Janssen Cilag France, Hexal, Johnson & Johnson, Ipsen, Genticel, Mabxience, Steba, IQVIA, Roche, Sensorion, Biophytis, and Servier, all outside the submitted work. Céleste Lebbe reports institutional research funding, personal fees, and nonfinancial support from BMS, institutional funding and personal fees from Roche, personal fees and nonfinancial support from MSD, and personal fees from Aventis, Novartis, Amgen, Pierre Fabre Laboratories, Pfizer, and Incyte, all outside the submitted work. Isabelle Borget reports research funding from the BMS Foundation during the course of the study and personal fees from Roche, Janssen, CSC Behring, Novartis, and Takeda outside the submitted work. The remaining authors made no disclosures., Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP), Hôpital de la Timone [CHU - APHM] (TIMONE)-Assistance Publique - Hôpitaux de Marseille (APHM)-Aix Marseille Université (AMU)

المصدر: Cancer
Cancer, 2020, 126 (3), pp.611-618. ⟨10.1002/cncr.32554⟩
Cancer, Wiley, 2020, 126 (3), pp.611-618. ⟨10.1002/cncr.32554⟩

مصطلحات موضوعية: Male, Cancer Research, MESH: Adolescent, Adult, Aged, 80 and over, Cohort Studies, Disease Progression, Female, France / epidemiology, Humans, Disease, Clinical practice, Targeted therapy, 0302 clinical medicine, Second line, Quality of life, Advanced disease, Medicine, Molecular Targeted Therapy, Prospective Studies, 030212 general & internal medicine, Neoplasm Metastasis, Melanoma, MESH: Immunotherapy, Melanoma / epidemiology, Melanoma / immunology, Melanoma / pathology, Melanoma / therapy, MESH: Middle Aged, Neoplasms, Second Primary / epidemiology, Young Adult, Real-life, Neoplasms, Second Primary, Middle Aged, 3. Good health, Survival Rate, Oncology, 030220 oncology & carcinogenesis, Cohort, France, Immunotherapy, medicine.medical_specialty, Adolescent, Metastatic melanoma, [SDV.CAN]Life Sciences [q-bio]/Cancer, 03 medical and health sciences, Internal medicine, In real life, Survival rate, Aged, business.industry, MESH: Neoplasms, Second Primary / immunology, Neoplasms, Second Primary / pathology, Quality of Life, business, [SDV.MHEP.DERM]Life Sciences [q-bio]/Human health and pathology/Dermatology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e7cc27d9b011eb68b46c2a487331edaTest
https://doi.org/10.1002/cncr.32554Test

المؤلفون: Aurélie De Roeck, Françoise Garima, Jean-Pierre Daurès, Laurent Meunier, Laure Cayrefourcq, Françoise Perriard, Pierre-Emmanuel Stoebner, C. Garcia, F. Fichel, Catherine Alix-Panabières

المساهمون: Aide à la Décision pour une Médecine Personnalisé - Laboratoire de Biostatistique, Epidémiologie et Recherche Clinique - EA 2415 (AIDMP), Université Montpellier 1 (UM1)-Université de Montpellier (UM), Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Institut des Biomolécules Max Mousseron [Pôle Chimie Balard] (IBMM), Centre National de la Recherche Scientifique (CNRS)-Institut de Chimie du CNRS (INC)-Université de Montpellier (UM)-Ecole Nationale Supérieure de Chimie de Montpellier (ENSCM), Service de Dermatologie [CHU Cochin], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Institut National de l'Environnement Industriel et des Risques (INERIS), Ecole Nationale Supérieure de Chimie de Montpellier (ENSCM)-Institut de Chimie du CNRS (INC)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)

المصدر: Cells
Volume 8
Issue 7
Cells, Vol 8, Iss 7, p 755 (2019)
Cells, MDPI, 2019, 8 (7), pp.755. ⟨10.3390/cells8070755⟩

مصطلحات موضوعية: Adult, Male, Oncology, Treatment response, medicine.medical_specialty, Population, CellSearch®, [SDV.CAN]Life Sciences [q-bio]/Cancer, circulating tumor cells, S100 protein, Article, 03 medical and health sciences, 0302 clinical medicine, Circulating tumor cell, Internal medicine, Biomarkers, Tumor, melanoma, Humans, Medicine, EPISPOT, In patient, Liquid biopsy, education, lcsh:QH301-705.5, Aged, 030304 developmental biology, Aged, 80 and over, 0303 health sciences, education.field_of_study, liquid biopsy, business.industry, Melanoma, S100 Proteins, General Medicine, Middle Aged, Neoplastic Cells, Circulating, medicine.disease, 3. Good health, Molecular Diagnostic Techniques, lcsh:Biology (General), Homogeneous, 030220 oncology & carcinogenesis, Female, business, Software

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::584687fd45ea62975e2fcab0bd32f7a8Test

المؤلفون: Céleste Lebbé, Anais Vallet, Raphaël Porcher, D. Legoupil, Thierry Lesimple, Bernard Guillot, Philippe Saiag, Jean-Philippe Lacour, Eve Maubec, Caroline Dutriaux, Florence Brunet-Possenti, Marie-Thérèse Leccia, Brigitte Dréno, Julie De Quatrebarbes, Bastien Oriano, Florence Granel-Brocard, Jean-Philippe Arnault, for MelBase, Laurent Mortier, Pierre-Emmanuel Stoebner, Clara Allayous, Stéphane Dalle, Sophie Dalac, François Aubin

المساهمون: Service de Dermatologie [AP-HP Hôpital Saint-Louis], Hopital Saint-Louis [AP-HP] (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre de Diagnostic et de Thérapeutique, Hôpital de l’Hôtel-Dieu [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL), CHU Bordeaux [Bordeaux], Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Institut d'oncologie/développement Albert Bonniot de Grenoble (INSERM U823), Université Joseph Fourier - Grenoble 1 (UJF)-CHU Grenoble-EFS-Institut National de la Santé et de la Recherche Médicale (INSERM), Hôpital du Bocage, Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Biomarqueurs et essais cliniques en Cancérologie et Onco-Hématologie (BECCOH), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Saclay, Institut National du Cancer [Boulogne Billancourt] (INC), Service de Dermatologie [Nice], Hôpital Archet 2 [Nice] (CHU), Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), Centre Hospitalier Annecy-Genevois [Saint-Julien-en-Genevois], AP-HP - Hôpital Bichat - Claude Bernard [Paris], Département d'oncologie médicale [Rennes], CRLCC Eugène Marquis (CRLCC), Service de dermatologie [CHU d'Amiens-Picardie], CHU Amiens-Picardie, Département de dermatologie, Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC)-Hôpital Saint-Jacques-Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Service de Dermatologie et Allergologie [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Institut des Biomolécules Max Mousseron [Pôle Chimie Balard] (IBMM), Ecole Nationale Supérieure de Chimie de Montpellier (ENSCM)-Institut de Chimie du CNRS (INC)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Service de dermatologie [Avicenne], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Avicenne [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Sorbonne Paris Nord, Centre de Recherche en Cancérologie Nantes-Angers (CRCNA), Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM)-PRES Université Nantes Angers Le Mans (UNAM)-Hôtel-Dieu de Nantes-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hôpital Laennec-Centre National de la Recherche Scientifique (CNRS)-Faculté de Médecine d'Angers-Centre hospitalier universitaire de Nantes (CHU Nantes), Service de dermatologie [Nantes], Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes), Laboratoire Dynamique des Protéines et Modélisation (LDPM), Université des Antilles et de la Guyane (UAG), Centre de Recherche Épidémiologie et Statistique Sorbonne Paris Cité (CRESS (U1153 / UMR_A_1125 / UMR_S_1153)), Université Paris Diderot - Paris 7 (UPD7)-Université Sorbonne Paris Cité (USPC)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de la Recherche Agronomique (INRA), Hôpital Hôtel-Dieu [Paris], Immunologie, dermatologie, oncologie, Oncodermatologie, immunologie et cellules souches cutanées (IDO (U976 / UMR_S 976)), Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM)

المصدر: JAMA Dermatol
JAMA Dermatology
JAMA Dermatology, American Medical Association, 2019, 155 (6), pp.673. ⟨10.1001/jamadermatol.2019.0425⟩

مصطلحات موضوعية: Male, Oncology, medicine.medical_specialty, Skin Neoplasms, Time Factors, [SDV.CAN]Life Sciences [q-bio]/Cancer, Dermatology, Cohort Studies, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, Interquartile range, Internal medicine, medicine, Humans, Prospective Studies, Progression-free survival, Neoplasm Metastasis, Stage (cooking), Prospective cohort study, Melanoma, Aged, Original Investigation, business.industry, Hazard ratio, MESH: Cohort studies, Melanoma/diagnosis, Middle aged, Skin neoplasms/diagnosis, Survival rate, Progression-Free survival, Middle Aged, Prognosis, Chemotherapy regimen, Progression-Free Survival, 3. Good health, Survival Rate, 030220 oncology & carcinogenesis, Localized disease, Cohort, Disease Progression, Female, France, Neoplasm Recurrence, Local, business, [SDV.MHEP.DERM]Life Sciences [q-bio]/Human health and pathology/Dermatology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d50085cf7a593e61cdb95478601f942Test
https://europepmc.org/articles/PMC6495357Test/

المؤلفون: Stéphane Dalle, Raphaël Porcher, Thierry Lesimple, Marie-Thérèse Leccia, Jean-Philippe Lacour, Sophie Dalac, D. Legoupil, Pauline Tétu, Sameh Mohamed, A. Ballon, Florence Brunet-Possenti, Céleste Lebbé, Clara Allayous, Laurent Mortier, François Aubin, Julie De Quatrebarbes, Pierre-Emmanuel Stoebner, Caroline Dutriaux, Bastien Oriano, Brigitte Dréno, Bernard Guillot, Philippe Saiag, Marie Beylot-Barry

المساهمون: Immunologie humaine, physiopathologie & immunothérapie (HIPI (UMR_S_976 / U976)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP), Centre de Diagnostic et de Thérapeutique, Hôpital de l’Hôtel-Dieu [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Laboratoire de Cytogénétique Constitutionnelle [Hospices civils de Lyon], Hospices Civils de Lyon (HCL), Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Centre Hospitalier Universitaire [Grenoble] (CHU), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Service de Dermatologie (CHU de Dijon), Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), CHU Bordeaux [Bordeaux], Service de Dermatologie [Nice], Hôpital Archet 2 [Nice] (CHU), Hôpital Ambroise Paré [AP-HP], AP-HP - Hôpital Bichat - Claude Bernard [Paris], Centre Hospitalier Annecy-Genevois [Saint-Julien-en-Genevois], Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), Hôpital Morvan - CHRU de Brest (CHU - BREST ), Centre Eugène Marquis (CRLCC), Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Centre hospitalier universitaire de Nantes (CHU Nantes), Service de biostatistique et information médicale de l’hôpital Saint Louis (Equipe ECSTRA) (SBIM), Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut national du cancer [Boulogne] (INCA)-Hopital Saint-Louis [AP-HP] (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université de Paris (UP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Cité (UPCité), CCSD, Accord Elsevier

المصدر: European Journal of Cancer
European Journal of Cancer, Elsevier, 2019, 112, pp.38-46. ⟨10.1016/j.ejca.2019.02.009⟩
European Journal of Cancer, 2019, 112, pp.38-46. ⟨10.1016/j.ejca.2019.02.009⟩

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, genetic structures, Propensity score, medicine.medical_treatment, [SDV.CAN]Life Sciences [q-bio]/Cancer, Systemic therapy, Targeted therapy, 03 medical and health sciences, 0302 clinical medicine, [SDV.CAN] Life Sciences [q-bio]/Cancer, Internal medicine, medicine, Humans, Prospective Studies, cardiovascular diseases, Stage (cooking), Prospective cohort study, Melanoma, Aged, Proportional Hazards Models, Radiotherapy, Brain Neoplasms, business.industry, MESH: Brain Neoplasms/radiotherapy, Melanoma/drug therapy, Melanoma/radiotherapy, Middle Aged, Brain metastases, medicine.disease, equipment and supplies, Advanced melanoma, Combined Modality Therapy, Confidence interval, 3. Good health, Radiation therapy, 030104 developmental biology, 030220 oncology & carcinogenesis, Propensity score matching, cardiovascular system, Female, Immunotherapy, business, circulatory and respiratory physiology

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4740f4de3a0995fc1c93c6462b8f58e5Test
https://hal.umontpellier.fr/hal-02872129/file/S0959804919301716.pdfTest

المؤلفون: Laurent Meunier, Jean-Marie Joujoux, C. Garcia, Pascal Roger, Pierre-Emmanuel Stoebner, M. Dandurand

المصدر: Dermatology. 228:103-106

مصطلحات موضوعية: Adult, Nosology, medicine.medical_specialty, Cutaneous Polyarteritis Nodosa, education, Dermatology, Disease, Skin Diseases, Vascular, Lymphocytic vasculitis, Severity of Illness Index, Asymptomatic, Hyperpigmented macules, Diagnosis, Differential, Hyperpigmentation, medicine, Humans, Lymphocytes, Arteritis, Leg, business.industry, Middle Aged, medicine.disease, Female, medicine.symptom, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f94f54c2770937751967c39e1e1371fTest
https://doi.org/10.1159/000356390Test

المؤلفون: Albert Sotto, Catherine Lechiche, Pierre Emmanuel Stoebner, Didier Laureillard, Christian Herlin, Christine Rollard, E. Rubenstein

المساهمون: Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), Institut des Biomolécules Max Mousseron [Pôle Chimie Balard] (IBMM), Centre National de la Recherche Scientifique (CNRS)-Institut de Chimie du CNRS (INC)-Université de Montpellier (UM)-Ecole Nationale Supérieure de Chimie de Montpellier (ENSCM), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Aide à la Décision pour une Médecine Personnalisé - Laboratoire de Biostatistique, Epidémiologie et Recherche Clinique - EA 2415 (AIDMP), Université Montpellier 1 (UM1)-Université de Montpellier (UM), Institut de Systématique, Evolution, Biodiversité (ISYEB ), Muséum national d'Histoire naturelle (MNHN)-École pratique des hautes études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS)-Université des Antilles (UA), Pathogénèse et contrôle des infections chroniques (PCCI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre Hospitalier Universitaire de Montpellier (CHU Montpellier ), Virulence bactérienne et maladies infectieuses (VBMI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Ecole Nationale Supérieure de Chimie de Montpellier (ENSCM)-Institut de Chimie du CNRS (INC)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Muséum national d'Histoire naturelle (MNHN)-Université des Antilles (UA)-Centre National de la Recherche Scientifique (CNRS)-École pratique des hautes études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Sorbonne Université (SU)

المصدر: Infection
Infection, Springer Verlag, 2016, 44 (3), pp.383-387. ⟨10.1007/s15010-015-0869-4⟩

مصطلحات موضوعية: Microbiology (medical), Adult, medicine.medical_specialty, Delayed Diagnosis, Spider Venoms, Biology, Skin infection, Loxosceles rufescens, Lesion, 030207 dermatology & venereal diseases, 03 medical and health sciences, Necrosis, 0302 clinical medicine, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Spider Bites, medicine, Animals, Humans, Medical history, Necrotic ulcer, Spider bite, Envenomation, Cutaneous loxoscelism, Phosphoric Diester Hydrolases, Spider bites, Leg Ulcer, Spiders, General Medicine, medicine.disease, biology.organism_classification, Loxoscelism, 3. Good health, Surgery, Infectious Diseases, Thigh, Asthenia, Chills, Female, France, medicine.symptom, 030217 neurology & neurosurgery

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::946564c23d3dfa735db0a4b033be1d6cTest
https://pubmed.ncbi.nlm.nih.gov/26744020Test

المؤلفون: François Habib, Laurent Meunier, Pierre-Emmanuel Stoebner, Gabriel Colonna, Luc Téot

المصدر: Dermatologic Surgery. 32:972-974

مصطلحات موضوعية: Adult, medicine.medical_specialty, Reconstructive surgery, Necrosis, medicine.medical_treatment, Dermatology, Varicose Veins, Dermis, Skin Ulcer, medicine, Humans, Ambulatory phlebectomy, Skin, Artificial, business.industry, General Medicine, Plastic Surgery Procedures, Surgery, medicine.anatomical_structure, Ambulatory Surgical Procedures, Ambulatory, Female, medicine.symptom, business, Vascular Surgical Procedures

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63de712cd2ac9146232ff5885f18a623Test
https://doi.org/10.1097/00042728-200607000-00022Test

المؤلفون: Laurent, Henry, Cécile, Fabre, Isabelle, Guiraud, Sophie, Bastide, Pascale, Fabbro-Peray, Jean, Martinez, Thierry, Lavabre-Bertrand, Laurent, Meunier, Pierre-Emmanuel, Stoebner

المصدر: International journal of cancer. 133(1)

مصطلحات موضوعية: Adult, Male, Proteasome Endopeptidase Complex, Skin Neoplasms, Enzyme-Linked Immunosorbent Assay, Kaplan-Meier Estimate, S100 Calcium Binding Protein beta Subunit, Plasma, Predictive Value of Tests, Biomarkers, Tumor, Humans, Nerve Growth Factors, Melanoma, Aged, Neoplasm Staging, Proportional Hazards Models, Aged, 80 and over, Extracellular Matrix Proteins, L-Lactate Dehydrogenase, S100 Proteins, Middle Aged, Prognosis, Neoplasm Proteins, Lymphatic Metastasis, Colorimetry, Female

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid________::3953100e4435b9afbaa3a8b6cd067cbbTest
https://pubmed.ncbi.nlm.nih.gov/23238767Test

المؤلفون: Laurent, Henry, Thierry, Lavabre-Bertrand, Thibaut, Douche, Sandrine, Uttenweiler-Joseph, Pascale, Fabbro-Peray, Bernard, Monsarrat, Jean, Martinez, Laurent, Meunier, Pierre-Emmanuel, Stoebner

المصدر: Experimental dermatology. 19(12)

مصطلحات موضوعية: Adult, Aged, 80 and over, Male, Proteasome Endopeptidase Complex, L-Lactate Dehydrogenase, Middle Aged, Prognosis, Survival Analysis, Disease-Free Survival, Protein Subunits, Young Adult, ROC Curve, Predictive Value of Tests, Recurrence, Humans, Female, Neoplasm Metastasis, Melanoma, Biomarkers, Aged, Neoplasm Staging

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid________::1cb1dc4418b96b463bfcb16ea132e2fcTest
https://pubmed.ncbi.nlm.nih.gov/20707810Test

المؤلفون: Pierre Emmanuel, Stoebner, Cécile, Fabre, Nelly, El Kabbaj, Michael, Bismuth, Georges Philippe, Pageaux, Laurent, Meunier

المصدر: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 15(8)

مصطلحات موضوعية: Risk, Laparotomy, Liver Diseases, Herpesviridae Infections, Hypertrophy, Middle Aged, Liver Transplantation, Diagnosis, Differential, Cicatrix, Risk Factors, Herpesvirus 8, Human, Humans, Female, Sarcoma, Kaposi, Immunosuppressive Agents

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid________::00d65edb124bff0ee4fafd17c32e126bTest
https://pubmed.ncbi.nlm.nih.gov/19642134Test